Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.52 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | DHFR | P00374 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27863649 | 0.85 | GABRA1 (0.39) | GABRA1GABRB2ESR1ESR2 | |
| SCHEMBL27787782 | 0.83 | DHFR (0.47) | GABRA1GABRB2CYP2C9CYP1A2CYP3A4 | |
| SCHEMBL7406801 | 0.80 | ALDH1A1 (0.39) | GABRA1GABRB2ALDH1A1 | |
| SCHEMBL6544890 | 0.79 | PRKCI (0.38) | GABRA1GABRB2DHFR | |
| SCHEMBL27787830 | 0.79 | SHBG (0.44) | GABRA1GABRB2ESR1ESR2DHFR | |
| SCHEMBL27876430 | 0.75 | GABRA1 (0.34) | GABRA1GABRB2ALOX15ALOX12ESR1 | |
| SCHEMBL8593252 | 0.75 | TYR (0.44) | GABRA1GABRB2CYP2C9CYP3A4ALOX15 | |
| SCHEMBL11811645 | 0.74 | GABRA1 (0.35) | GABRA1GABRB2CYP2C9CYP3A4ALOX15 | |
| SCHEMBL743996 | 0.74 | GABRA1 (0.31) | GABRA1GABRB2 | |
| SCHEMBL458311 | 0.74 | ALDH1A1 (0.31) | GABRA1GABRB2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104428700-B | Polarization plates and organic EL panel | 日东电工株式会社 | 2017-03-01 | — | — | CN | disclosed |
| CN-106068177-A | Increase material manufacture has the goods of anti-flammability, method for making and tests their method of anti-flammability | 沙特基础工业全球技术有限公司 | 2016-11-02 | — | — | CN | disclosed |
| CN-104017199-B | Polycarbonate and method for producing same | 三菱化学株式会社 | 2016-08-31 | — | — | CN | disclosed |
| CN-102985489-B | Method for producing polyphenylene ether resin composition | MITSUBISHI ENG PLASTICS CORP | 2015-06-10 | — | — | CN | disclosed |
| CN-102596524-B | Production method for molded body of polyphenylene ether resin composition | MITSUBISHI ENG PLASTICS CORP | 2014-12-03 | — | — | CN | disclosed |
| CN-102869482-B | Process for production of polyphenylene ether resin molded article | MITSUBISHI ENG PLASTICS CORP | 2014-11-05 | — | — | CN | disclosed |
| WO-2014121036-A1 | 5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | DEUTERX, LLC (US) | 2014-08-07 | — | — | WO | disclosed |
| US-20140221369-A1 | 5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | DEUTERX, LLC (US) | 2014-08-07 | — | — | US | disclosed |
| CN-102985489-A | Method for producing polyphenylene ether resin composition | MITSUBISHI ENG PLASTICS CORP | 2013-03-20 | — | — | CN | disclosed |
| CN-102869482-A | Process for production of polyphenylene ether resin molded article | MITSUBISHI ENG PLASTICS CORP | 2013-01-09 | — | — | CN | disclosed |
| US-4772741-A | STABILIZERS FOR POLYMERS | MILLINCKRODT, INC. (US) | 1988-09-20 | — | — | US | disclosed |
| EP-0069195-B1 | STABILIZED ETHYLENE/CHLOROTRIFLUOROETHYLENE COPOLYMER COMPOSITION | Ausimont, U.S.A., Inc. (US) | 1988-08-24 | — | — | EP | disclosed |
| US-4734519-A | STABILIZERS | MALLINCKRODT, INC. (US) | 1988-03-29 | — | — | US | disclosed |
| EP-0250087-A1 | Pentaerythritol co-esters | MALLINCKRODT, INC. (US) | 1987-12-23 | — | — | EP | disclosed |
| US-4539354-A | PHOSPHITE DERIVATIVE OF A PHENOL, A GROUP II METAL CARBOXYLATE ANDAN ESTER OF A POLYOL | ALLIED CORPORATION (US) | 1985-09-03 | — | — | US | disclosed |
| EP-0110682-A2 | Activated aryl capped fluorescent compounds, and assay methods and systems using them as fluorogenic precursors | SYVA COMPANY (US) | 1984-06-13 | — | — | EP | disclosed |
| EP-0069195-A2 | Stabilized ethylene/chlorotrifluoroethylene copolymer composition | Ausimont, U.S.A., Inc. (US) | 1983-01-12 | — | — | EP | disclosed |
| EP-0032586-A2 | Durable polyester molding composition | GAF CORPORATION (US) | 1981-07-29 | — | — | EP | disclosed |
| US-4277391-A | CONTAINING THREE DIFFERENT TYPES OF ANTIOXIDANTS | GAF CORPORATION (US) | 1981-07-07 | — | — | US | disclosed |
| US-4098760-A | NON-MIGRATORY, NON-LEACHING | UNIROYAL, INC. (US) | 1978-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221369-A1 | 5-DEUTERO-2,4-THIAZOLIDINEDIONE AND 5-DEUTERO-2,4-OXAZOLIDINEDIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | SRD5A2, PPARD, SRD5A1 | GABRA1 2477/4885GABRB2 2444/4885CYP2C9 400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.